Trials / Completed
CompletedNCT04187586
Effect of Extracorporeal Shock Wave Therapy for Burn Scar Charateristics
Effect of Extracorporeal Shock Wave Therapy for Burn Scar Charateristics: A Retrospective Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 35 (actual)
- Sponsor
- Hangang Sacred Heart Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- —
Summary
No study has investigated the effect of extracorporeal shock wave therapy (ESWT) on hypertrophic scar characteristics. Thus, this study aimed to ascertain the effects ESWT on burn scars. The investigators retrospectively reviewed burn patients who had undergone autologous split-thickness skin grafting (STSG) with same artificial dermis between January 2012 and September 2019.
Detailed description
No study has investigated the effect of extracorporeal shock wave therapy (ESWT) on hypertrophic scar characteristics. Thus, this study aimed to ascertain the effects ESWT on burn scars. The investigators retrospectively reviewed burn patients who had undergone autologous split-thickness skin grafting (STSG) with same artificial dermis between January 2012 and September 2019. The ESWT group (n=17) received shock waves with low-energy flux density (0.05-0.30 mJ/mm2). The interval between treatments is a 1-week. The ESWT group also received standard treatment. The control group (n=18) only received standard treatment. We reviewed skin characteristics before and after 6 treatment sessions for both groups. The investigators checked skin charateristics(erythema, transepidermal water loss, sebum level, and elasticity). The investigators expect that ESWT is effective for significantly improving burn-associated scar characteristics and may be used for managing burn patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Extracorporeal shock wave therapy | ESWT was performed around the primary treatment site at 100 impulses/cm2, an energy flux density(EFD) of 0.05 to 0.30 mJ/mm2, frequency of 4Hz, and 1000 to 2000 impulses were administered at 1-week intervals for 6 sessions. |
Timeline
- Start date
- 2019-12-10
- Primary completion
- 2019-12-12
- Completion
- 2019-12-12
- First posted
- 2019-12-05
- Last updated
- 2019-12-16
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04187586. Inclusion in this directory is not an endorsement.